227 related articles for article (PubMed ID: 32369445)
21. STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.
He J; Shi J; Xu X; Zhang W; Wang Y; Chen X; Du Y; Zhu N; Zhang J; Wang Q; Yang J
J Biosci; 2012 Jun; 37(2):243-57. PubMed ID: 22581330
[TBL] [Abstract][Full Text] [Related]
22. Coronary artery abnormalities in Hyper-IgE syndrome.
Freeman AF; Avila EM; Shaw PA; Davis J; Hsu AP; Welch P; Matta JR; Hadigan C; Pettigrew RI; Holland SM; Gharib AM
J Clin Immunol; 2011 Jun; 31(3):338-45. PubMed ID: 21494893
[TBL] [Abstract][Full Text] [Related]
23. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
[TBL] [Abstract][Full Text] [Related]
24. Lung disease in STAT3 hyper-IgE syndrome requires intense therapy.
Kröner C; Neumann J; Ley-Zaporozhan J; Hagl B; Meixner I; Spielberger BD; Dückers G; Belohradsky BH; Niehues T; Borte M; Rosenecker J; Kappler M; Nährig S; Reu S; Griese M; Renner ED
Allergy; 2019 Sep; 74(9):1691-1702. PubMed ID: 30793327
[TBL] [Abstract][Full Text] [Related]
25. HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.
Heun Y; Pogoda K; Anton M; Pircher J; Pfeifer A; Woernle M; Ribeiro A; Kameritsch P; Mykhaylyk O; Plank C; Kroetz F; Pohl U; Mannell H
Mol Ther; 2017 Jul; 25(7):1616-1627. PubMed ID: 28434868
[TBL] [Abstract][Full Text] [Related]
26. Phenotyping and long-term follow up of patients with hyper IgE syndrome.
Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R
Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075
[TBL] [Abstract][Full Text] [Related]
27. The hyper-IgE syndromes.
Freeman AF; Holland SM
Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
[TBL] [Abstract][Full Text] [Related]
28. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
29. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
30. STAT3 mutation-associated airway epithelial defects in Job syndrome.
Zhang Y; Lin T; Leung HM; Zhang C; Wilson-Mifsud B; Feldman MB; Puel A; Lanternier F; Couderc LJ; Danion F; Catherinot E; Salvator H; Tcherkian C; Givel C; Xu J; Tearney GJ; Vyas JM; Li H; Hurley BP; Mou H
J Allergy Clin Immunol; 2023 Aug; 152(2):538-550. PubMed ID: 36638921
[TBL] [Abstract][Full Text] [Related]
31. An Unexpected Infection in Loss-of-Function Mutations in STAT3: Malignant Alveolar Echinococcosis in Liver.
Haskologlu S; Dogu F; Gollu Bahadır G; Akyuzluer S; Ciftci E; Altun D; Keles S; Kologlu M; Ikinciogullari A
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):667-675. PubMed ID: 33463136
[TBL] [Abstract][Full Text] [Related]
32. [STAT3 mutation in a child with hyper-IgE syndrome and incomplete clinical features].
Szaflarska A; Rutkowska-Zapała M; Pituch-Noworolska A; Siedlar M
Przegl Lek; 2015; 72(12):787-90. PubMed ID: 27024962
[TBL] [Abstract][Full Text] [Related]
33. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered?
Oikonomopoulou C; Goussetis E
Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403
[TBL] [Abstract][Full Text] [Related]
34. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
35. Bone density and fractures in autosomal dominant hyper IgE syndrome.
Sowerwine KJ; Shaw PA; Gu W; Ling JC; Collins MT; Darnell DN; Anderson VL; Davis J; Hsu A; Welch P; Puck JM; Holland SM; Freeman AF
J Clin Immunol; 2014 Feb; 34(2):260-4. PubMed ID: 24402620
[TBL] [Abstract][Full Text] [Related]
36. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.
Goel S; Sahu S; Minz RW; Singh S; Suri D; Oh YM; Rawat A; Sehgal S; Saikia B
Front Immunol; 2018; 9():1080. PubMed ID: 29868029
[TBL] [Abstract][Full Text] [Related]
37. Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome.
Freeman AF; Renner ED; Henderson C; Langenbeck A; Olivier KN; Hsu AP; Hagl B; Boos A; Davis J; Marciano BE; Boris L; Welch P; Sawalle-Belohradsky J; Belohradsky BH; Kwong KF; Holland SM
J Clin Immunol; 2013 Jul; 33(5):896-902. PubMed ID: 23584561
[TBL] [Abstract][Full Text] [Related]
38. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W
Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127
[TBL] [Abstract][Full Text] [Related]
39. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair.
Mace KA; Yu DH; Paydar KZ; Boudreau N; Young DM
Wound Repair Regen; 2007; 15(5):636-45. PubMed ID: 17971009
[TBL] [Abstract][Full Text] [Related]
40. A hypoxia response element in the Vegfa promoter is required for basal Vegfa expression in skin and for optimal granulation tissue formation during wound healing in mice.
Ciarlillo D; Celeste C; Carmeliet P; Boerboom D; Theoret C
PLoS One; 2017; 12(7):e0180586. PubMed ID: 28686658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
